Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

F.P.M. O'Harte; V.A. Gault; Patrick Harriott; Brian Green; P.R. Flatt

Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

F.P.M. O'Harte
, V.A. Gault
, Patrick Harriott
, Brian Green
, P.R. Flatt

School of Biological Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	A178
Journal	Diabetologia
Volume	45
Issue number	S2
Publication status	Published - 2002

Cite this

@article{c4422269bf214bd39b962912793ecc9a,

title = "Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.",

author = "F.P.M. O'Harte and V.A. Gault and Patrick Harriott and Brian Green and P.R. Flatt",

year = "2002",

language = "English",

volume = "45",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "S2",

}

Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis. / O'Harte, F.P.M.; Gault, V.A.; Harriott, Patrick et al.
In: Diabetologia, Vol. 45, No. S2, A178, 2002.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Comparative studies with exendin(9-39)amide and the novel (Pro3)GIP receptor antagonist indicates that glucose-dependent insulinotropic polypeptide is the major hormone of the enteroinsular axis.

AU - O'Harte, F.P.M.

AU - Gault, V.A.

AU - Harriott, Patrick

AU - Green, Brian

AU - Flatt, P.R.

PY - 2002

Y1 - 2002

M3 - Meeting abstract

SN - 0012-186X

VL - 45

JO - Diabetologia

JF - Diabetologia

IS - S2

M1 - A178

ER -